A European multidisciplinary network for the fight against HIV drug resistance
A European multidisciplinary network for the fight against HIV drug resistance
EuResist Network is an international non-profit partnership devoted to understanding and fighting the resistance to anti-HIV drugs.
Its approach is eminentely multidisciplinary and focused on exploiting the power of real world data at the benefit of the individual patient…
The EuResist Integrated Database
with data of more than 105.000 HIV patients is open for research studies.
EuResist
News
New publication “Data privacy, data property and data sharing” in post-pandemic research
The book on “Data privacy, data property and data sharing” was published by Routledge on 16 December 2025.This publication addresses
EuResist Network Joins Key Bilateral Event in China
EuResist Network has been selected to participate in the XIV China-Italy Science, Technology, and Innovation Week. This prestigious event for
CARE4ART resutls presented at the 20th European AIDS Conference
EuResist Network GEIE was at the 20th European AIDS Conference for insights on INSTI resistance in people with HIV-1A6!A poster
New publication “Data privacy, data property and data sharing” in post-pandemic research
The book on “Data privacy, data property and data sharing”
EuResist Network Joins Key Bilateral Event in China
EuResist Network has been selected to participate in the XIV
CARE4ART resutls presented at the 20th European AIDS Conference
EuResist Network GEIE was at the 20th European AIDS Conference
EuResist Celebrates EU Day at the AREVIR meeting with a focus on Collaborative EU Project
Today, May 9th, marks EU Day, a celebration of European
EuResist
They talk about us
Scuole e pandemia, i risultati dello studio EuCare: aumentati i disturbi psico-sociali mentre è calato l’apprendimento
The Italian economic Newspaper “Il Sole 24 ORE” reported on the EuCARE Schools Study, which detailed the devastating impact of the pandemic on students’ mental health. The study revealed a significant increase in anxiety, depression, and other psychosocial disorders, alongside a noticeable drop in academic performance. Read full article here.
EuCARE per capire l’impatto delle varianti di SARS-CoV-2
The Italian economic Newspaper “Il Sole 24 ORE” published a piece called “Guida Progetti Europei”, with a focus on the main European projects with Italian partners. The published guide accomplished to deliver a very important and impactful resume about the EuCARE project highlighting the main research focuses and its results. Furthermore, the article described the project collaborations established and the partners involved.
La didattica a distanza migliora voti e fiducia negli studenti? Gli studi scientifici dicono altro.
EuCARE article published online on Il fatto quotidiano about distance learning and the impact on students grades and confidence.
EuCARE studia l’impatto del Covid-19: quali sono le migliori azioni da intraprendere in situazioni di emergenza.
EuCARE and the issue of preparedness on Il Sole 24 Ore, Italy’s leading business daily newspaper.
EuResist
Projects
INBIOMEDvision
INBIOMEDvision was a Coordination and Support Action aiming to promote Biomedical Informatics (BMI) by means of the permanent monitoring of the scientific state-of-the-art and the identification of common grounds and potential synergies between current Bioinformatics and Medical Informatics approaches. The
EuCARE
Coordinated by Euresist Network, 25 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. This is the EuCARE Project! How do SARS-COV-2 variants, coupled with other
VIROMARKERS
The overall aim of VIROMARKERS is to define virus related biomarkers to improve management of chronic diseases, including biomarkers of response to antiviral treatment of persistent viral infections and virome features as indicators of disease progression in immunosuppressed people. Validation
INBIOMEDvision
INBIOMEDvision was a Coordination and Support Action aiming to promote Biomedical Informatics (BMI) by means of the permanent monitoring of the scientific state-of-the-art and the identification of common grounds and potential synergies between current Bioinformatics and Medical Informatics approaches. The
EuCARE
Coordinated by Euresist Network, 25 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. This is the EuCARE Project! How do SARS-COV-2 variants, coupled with other
VIROMARKERS
The overall aim of VIROMARKERS is to define virus related biomarkers to improve management of chronic diseases, including biomarkers of response to antiviral treatment of persistent viral infections and virome features as indicators of disease progression in immunosuppressed people. Validation
AVITHRAPID
The fight against global health threats from viral diseases takes a big step forward with AVITHRAPID “Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases”. This ambitious project aims to create a pipeline of promising antiviral drugs built on existing